Please login to the form below

Not currently logged in
Email:
Password:

Kovaltry

This page shows the latest Kovaltry news and features for those working in and with pharma, biotech and healthcare.

Shire claims EU approval for haemophilia A drug Adynovi

Shire claims EU approval for haemophilia A drug Adynovi

Shire claims EU approval for haemophilia A drug Adynovi. The drug will battle Bayer’s Kovaltry and Sobi's Elocta in a bid to capture market share. ... Bayer does not separate Kovaltry from its short-acting predecessor Kogenate but reported combined

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics